Yes — more than most people realize, and less settled than its strongest advocates claim. Here is the honest, sourced answer, with every study behind it one click away.
Where the research is strongest. Each links to the full study list.
Yes — with caveats worth understanding. EFT/Tapping is documented across 407 studies and reviews catalogued here — 300 primary studies plus 107 reviews and meta-analyses — including 99 randomized controlled trials and 42 meta-analyses and systematic reviews, published in peer-reviewed medical and psychology journals across 8 languages. Meta-analyses report large average effects for anxiety, depression, and PTSD. The fair criticism is that some trials use waitlist rather than active comparison groups and rely on self-report, and that more head-to-head trials against treatments like CBT are needed. The accurate one-line answer: Tapping has a real and growing peer-reviewed evidence base, stronger than most people assume, and still maturing.
This directory catalogues 99 randomized controlled trials of EFT/Tapping, alongside 42 meta-analyses and systematic reviews and many pilot, outcome, and case studies — 407 unique publications in total, each listed with its design, sample size, and original source.
Published meta-analyses report large pooled effect sizes for Tapping on anxiety (Clond, 2016), depression (Nelms & Castel, 2016; Seok & Kim, 2024), and PTSD (Sebastian & Nelms, 2017), typically in the range considered 'large' in psychology. Each of these, with its exact figures and confidence intervals, is listed and linked in this directory.
The main criticisms are that early trials often compared tapping to a waitlist rather than an active treatment, that many outcomes are self-reported, and that 'dismantling' studies question whether the acupressure points add anything beyond the exposure and cognitive elements. These are legitimate points and we list the critical and null studies openly, right alongside the positive ones. What the 'pseudoscience' label misses is the size of the peer-reviewed literature: hundreds of studies, including RCTs and meta-analyses in indexed journals.
Tapping's evidence has been evaluated against the American Psychological Association's published criteria for empirically supported treatments, and several reviews argue it meets that threshold for conditions like PTSD and anxiety. To be clear: that is a claim made in peer-reviewed papers, not an official APA designation, and the APA has not endorsed Tapping. It does not have the decades of endorsement that treatments like CBT have. The honest framing is that it is an evidence-supported technique whose formal recognition is still catching up to its research base.
Named examples, all checkable. Bond University in Australia runs a dedicated research program that has produced multiple randomized trials, including a 147-person chronic pain trial and a cortisol replication study. In Belgium, the Kortrijk Cancer Centre led a multicentre randomized trial in cancer survivors with co-authors at Ghent University, the University Hospital Brussels, and KU Leuven, published in a Lancet-family journal (eClinicalMedicine); the same group is now running a follow-on trial across eleven Belgian hospitals, including four university hospitals (ClinicalTrials.gov NCT06175208). And the UK's national guideline body, NICE, reviewed Tapping in its 2018 PTSD guideline evidence review: it found promising evidence for self-rated PTSD symptoms, stopped short of a treatment recommendation, and issued a formal research recommendation calling for more trials. The picture: real universities and hospital systems are running Tapping trials, the trials keep getting larger and better controlled, and the field is building exactly the head-to-head evidence its reviewers have asked for.
This page summarizes the full Tapping Evidence Base — 407 studies and reviews, openly sourced, including the criticisms and null results. See the methodology for how it was compiled, or explore the data visually.